Pharmacokinetic-Pharmacodynamic Relationship of the Selective Serotonin Reuptake Inhibitors

@article{Baumann1996PharmacokineticPharmacodynamicRO,
  title={Pharmacokinetic-Pharmacodynamic Relationship of the Selective Serotonin Reuptake Inhibitors},
  author={P. Baumann},
  journal={Clinical Pharmacokinetics},
  year={1996},
  volume={31},
  pages={444-469}
}
  • P. Baumann
  • Published 1996
  • Medicine
  • Clinical Pharmacokinetics
  • SummaryThe recently introduced antidepressants, the selective serotonin reuptake inhibitors (SSRIs) [citalopram, fluoxetine, fluvoxamine, paroxetine and sertraline], are known for their clinical efficacy, good tolerability and relative safety. They differ from each other in chemical structure, metabolism and pharmacokinetic properties. Therapeutic drug monitoring of these compounds is not widely used, as the plasma concentration ranges within which clinical response with minimal adverse effects… CONTINUE READING
    Metabolism and Pharmacokinetics of Selective Serotonin Reuptake Inhibitors
    • 135
    • Highly Influenced
    Metabolism of the Newer Antidepressants
    • 122

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 168 REFERENCES